Literature DB >> 7472291

Modification of fat and carbohydrate metabolism by neurohypophyseal hormones. III. Effect of oxytocin on non-esterified fatty acid, glucose, triglyceride and cholesterol levels in rat serum.

J Sůva, D Caisová, A Stajner.   

Abstract

The authors determined the effect of s.c. injected oxytocin on serum non-esterified fatty acid, triglyceride, cholesterol and glucose levels in fed and fasting rats of both sexes, in doses of 2.5 and 5 I.U./kg. No changes in non-esterified fatty acid levels were found in fasting animals of either sex. In fed males, non-esterified fatty acid levels rose abruptly after both doses; in fed females they fell after the larger dose. In fed animals of both sexes, the smaller dose of oxytocin produced a decrease, and the larger dose an increase, in triglyceride levels. In fasting females, triglyceride levels fell after both doses; in fasting males a temporary increase was found after the larger dose. In the great majority of cases cholesterol levels displayed a tendency to fall, in both males and females. In the case of glucose, a transient increase was recorded in fed animals of both sexes after the smaller dose and a decrease in males after the larger dose. In fasting animals, glucose levels temporarily rose in every case.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7472291

Source DB:  PubMed          Journal:  Endokrinologie        ISSN: 0013-7251


  3 in total

Review 1.  Therapeutic Potential of Oxytocin in Atherosclerotic Cardiovascular Disease: Mechanisms and Signaling Pathways.

Authors:  Ping Wang; Stephani C Wang; Haipeng Yang; Chunmei Lv; Shuwei Jia; Xiaoyu Liu; Xiaoran Wang; Dexin Meng; Danian Qin; Hui Zhu; Yu-Feng Wang
Journal:  Front Neurosci       Date:  2019-05-21       Impact factor: 4.677

Review 2.  Cardiovascular protective properties of oxytocin against COVID-19.

Authors:  Stephani C Wang; Yu-Feng Wang
Journal:  Life Sci       Date:  2021-01-26       Impact factor: 6.780

Review 3.  Chronic Oxytocin Administration as a Treatment Against Impaired Leptin Signaling or Leptin Resistance in Obesity.

Authors:  Jordi Altirriba; Anne-Laure Poher; Françoise Rohner-Jeanrenaud
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-05       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.